Global Human Insulin Market 2015-2019 Released On 30th September 2015
About diabetes Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as Human insulin and insulin analogs are available as insulin replacement therapy. JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Technavios analysts forecast the global human insulin market to grow at a CAGR of 10.29% over the period 2014-2019.
Covered in this Report The report includes the present scenario and the growth prospects of the Global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes.
Technavios report, Global Human Insulin Market 2015-2019, has been prepared based on an indepth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.
Key Vendors Eli Lilly Novo Nordisk Sanofi
Other Prominent Vendors Biocon Biodel Biogenomics Boehringer Ingelheim JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Bristol-Myers Squibb Diamyd Medical Diasome Pharmaceuticals DiaVacs Pfizer Generex Biotechnology Lexicon Pharmaceuticals Macrogenics Merck Oramed Pharmaceuticals Osiris Therapeutics Thermalin Diabetes Tolerion Wockhardt XOMA Corporation
Market Driver Increase in prevalence of diabetes For a full, detailed list, view our report
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Market Challenge Stringent regulatory environment For a full, detailed list, view our report
Market Trend Increasing R&D for novel mechanisms For a full, detailed list, view our report
Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Browse complete Report on: http://www.jsbmarketresearch.com/healthcare-medical/r-global-human-insulin-market194646
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Table of Contents
PART 01: Executive summary Highlights
PART 02: Scope of the report Market overview Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology Research methodology Economic indicators
PART 05: Disease overview Epidemiology
PART 06: Pipeline analysis JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
PART 07: Introduction Key market highlights
PART 08: Market landscape Market overview Market size and forecast Five forces analysis
PART 09: Market segmentation by type of insulin Fast-acting insulin Intermediate-acting insulin Long-acting insulin
PART 10: Market segmentation by type of disease
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape Competitive scenario Market share analysis 2014 Other prominent vendors
PART 18: Key vendor analysis Lilly Novo Nordisk Sanofi
PART 19: Appendix List of abbreviation
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
PART 20: Explore Technavio
List of Exhibits Exhibit 01: Product offerings Exhibit 02: Diabetes prevalence rate in various countries (2000 and 2030) Exhibit 03: Global human insulin market 2014-2019 ($ Billions) Exhibit 04: Five forces analysis Exhibit 05: Global human insulin market by type of disease 2014 Exhibit 07: Global human insulin market segmentation by geography 2014 Exhibit 08: Impact of drivers Exhibit 09: Impact of drivers and challenges Exhibit 10: Novo Nordisk: Company strategy Exhibit 11: Modern insulins: Drug sales 2010-2014 ($ millions) Exhibit 12: NovoRapid/NovoLog: Drug sales 2010-2014 ($ millions) Exhibit 13: Levemir: Drug sales 2010-2014 ($ millions) Exhibit 14: NovoMix: Drug sales 2010-2014 ($ millions) Exhibit 15: Human insulins: Drug sales 2010-2014 ($ millions) Exhibit 16: Sanofi: Company strategy Exhibit 17: Lantus: Drug sales 2010-2014 ($ millions) Exhibit 18: Apidra: Drug sales 2010-2014 ($ millions) JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Exhibit 19: Insuman: Drug sales 2010-2014 ($ millions) Exhibit 20: Lilly: Company strategy Exhibit 21: Humalog: Drug sales 2010-2014 ($ millions) Exhibit 22: Humulin: Drug sales 2010-2014 ($ millions) Exhibit 23: Novo Nordisk: R&D expenditure 2014
Related reports:
Japan Vitamin A Industry 2015 Market Research Report Europe Vitamin A Industry 2015 Market Research Report United States Vitamin A Industry 2015 Market Research Report Global Encephalitis Vaccination Industry 2015 Market Research Report Global Glass-ionomer Cement Industry 2015 Market Research Report
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stopshop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on “Global Human Insulin Market 2015-2019� http://www.jsbmarketresearch.com/healthcare-medical/r-global-human-insulin-market194646
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/